Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × gedatolisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Neoplasms 4 Triple Negative Breast Neoplasms 3 Neoplasm Metastasis 3 Endometrial Neoplasms 3 Colorectal Neoplasms 2 Uterine Neoplasms 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Prostatic Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Myelodysplastic Syndromes 1 Male Urogenital Diseases 1 Leukemia, Myeloid, Acute 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Genital Diseases, Male 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasm Malignant Female 1

Interventions

Cisplatin 43 Carboplatin 38 pembrolizumab 36 Paclitaxel 32 Gemcitabine 27 Pemetrexed 18 Radiotherapy 17 Magnetic Resonance Spectroscopy 17 Radiotherapy, Intensity-Modulated 16 Docetaxel 16 Cetuximab 16 Nivolumab 14 Specimen Handling 13 Cyclophosphamide 13 durvalumab 12 Fluorouracil 12 Sorafenib 10 130-nm albumin-bound paclitaxel 10 Sunitinib 9 Platinum 9 Bevacizumab 9 osimertinib 8 Radiation 8 1,2-diaminocyclohexaneplatinum II citrate 8 Oxaliplatin 7 Irinotecan 7 Everolimus 7 Drug Therapy 7 Capecitabine 7 fludarabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02920450 2019-10-04

UF-STO-LUNG-002

University of Florida

Phase 1/2 Terminated

3 enrolled 8 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡